Think Twice, exercise caution and generally avoid making assumptions about patient risk of subsequent prescription opioid use disorder, write authors
Moving on: helping young people
In this 2009 Insight article, Gemma Turner, Cobh Community Based Drugs Worker, provides a brief history of the project while Jano Klimas gives a sense
Expanding opioid agonist therapy while learning from HIV/AIDS
Accessing opioid agonist therapy (OAT) and maintaining good adherence faces many barriers which can be geographical, financial, regulatory,
Finding good endpoints for diagnostic test accuracy reviews on substance use
Diagnostic test accuracy reviews increasingly are being used in substance use research, yet the majority of the studies considered in these reviews do
Irish Canadian project highlights global issue
This toolkit is based on a study that aimed to establish the feasibility and accessibility of training primary care practitioners in addiction
Towards a research agenda for addiction education in Europe, u21 poster
u21 health sciences group 2020 virtual meeting: A collaborative approach to healthcare was hosted by University College Dublin from August 25th -
Can stimulants treat stimulant use disorder?
This ‘systematic overview of reviews’ assembled the evidence for stimulant use disorder treatments from the systematic reviews of literature.
Eight years joining CPDD drug problems conference
Some things in academia can become so much fabric of your life that you stop counting years. The conference of the College on Problems of Drug
Can prescribers avoid contributing to opioid use disorder?
A 21 y/o has surgery for a condition expected to improve. He fills a discharge prescription for 5 days of an opioid at a standard dose. At 1-week